Clinical microbiologica case: Infection imitating lymphocutaneous sporotrichosis during pregnancy in a healthy woman from the south-eastern USA

Clinical Microbiology and Infection

Volumn 9, Issue 3, 2003, Pages 221-

  Safdar, Amar ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; IMIPENEM; TOBRAMYCIN;

ADULT; ARTICLE; BACTERIUM ISOLATION; BONE SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DNA SEQUENCE; FEMALE; HUMAN; MYCOBACTERIUM FORTUITUM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; SEROLOGY; SKIN BIOPSY; SKIN GRANULOMA; SKIN NODULE; SPOROTRICHOSIS; UNITED STATES; ATYPICAL MYCOBACTERIOSIS; BACTERIAL SKIN DISEASE; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; GENETICS; ISOLATION AND PURIFICATION; LYMPHATIC SYSTEM DISEASE; MICROBIOLOGY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; TIBIA;

BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM FORTUITUM;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHATIC DISEASES; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INFECTIONS, ATYPICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SKIN DISEASES, BACTERIAL; SOUTHEASTERN UNITED STATES; SPOROTRICHOSIS; TIBIA;

EID: 0038389060     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00585.x     Document Type: Article

References (28)

1. Nolte FS, Metchock B. Mycobacterium. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology. Washington, DC: ASM Press, 1995; 400-37.
2. Swenson JM, Thornsberry C, Silcox VA. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother 1982; 22: 186-92.
3. Escalonilla P, Esteban J, Soriano ML et al. Cutaneous manifestations of infections by nontuberculous mycobacteria. Clin Exp Dermatol 1998; 23: 214-21.
4. Demitsu T, Nagato H, Inoue T et al. Cutaneous Mycobacterium chelonae infection with bilateral sporotrichoid involvement. Int J Dermatol 2001; 40: 597-9.
5. Greer KE, Gross GP, Martensen SH. Sporotrichoid cutaneous infection due to Mycobacterium chelonei. Arch Dermatol 1979; 115: 738-9.
6. Fitzgerald DA, Smith AG, Lees A et al. Cutaneous infection with Mycobacterium abscessus. Br J Dermatol 1995; 132: 800-4.
7. Wallace RJ Jr, Brown BA, Griffith DE. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria. Annu Rev Microbiol 1998; 52: 453-90.
8. Murillo J, Torres J, Bofill L et al. Skin and wound infection by rapidly growing mycobacteria: an unexpected complication of liposuction and liposculpture. The Venezuelan Collaborative Infectious and Tropical Diseases Study Group. Arch Dermatol 2000; 136: 1347-52.
9. Toth EL, Boychuk LR, Kirkland PA. Recurrent infection of continuous subcutaneous insulin infusion sites with Mycobacterium fortuitum. Diabetic Care 1998; 18: 1284-5.
10. Nagore E, Ramos P, Botella-Estrada R, Ramos-Niguez JA, Sanmartin O, Castejon P. Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with triple drug regimen. Acta Dermatovenerelogica 2001; 81: 291-3.
11. O'Brien DP, Rawluk DJ. Iatrogenic Mycobacterium infection after an epidural injection. Spine 1999; 24: 1257-9.
12. Katayama I, Nishioka K, Nishiyama S. Mycobacterium fortuitum infection presenting as widespread cutaneous abscess in a pregnant woman. Int J Dermatol 1990; 29: 383-4.
13. Silvestre Salvador JF, Betlloch MI, Alfanso R, Ramon RL, Morell AM, Navas J. Disseminated skin infection due to Mycobacterium fortuitum in an immunocompetent patient. J Eur Acad Dermatol Venereol 1998; 11: 158-61.
14. Passeron T, Desruelles F, Fosse T et al. Disseminated papulopustular eruption due to Mycobacterium fortuitum in an immunocompetent patient. Clin Infect Dis 1999; 28: 924-5.
15. Retief CR, Tharp MD. Mycobacterium fortuitum panniculitis in a steroid-dependent asthmatic patient. J Am Acad Dermatol 1998; 39: 650-3.
16. Smego RA, Castiglia M, Asperilla MO. Lymphocutaneous syndrome. Medicine 1999; 78: 38-63.
17. Canet JJ, Pagerols X, Sanchez C, Vives P, Garau J. Lymphocutaneous syndrome due to Scedosporium apiospermum. Clin Microbiol Infect Dis 2001; 7: 648-52.
18. Leigheb G, Mossini A, Boggio P, Gattoni M, Bornacina G, Griffanti P. Sporotrichosis-like lesions caused by a Paecilomyces genus fungus. Int J Dermatol 1994; 33: 275-6.
19. Smith MB, Schnadig VJ, Boyars MC, Woods GL. Clinical and pathologic features of Mycobacterium fortuitum infections. An emerging pathogen in patients with AIDS. Am J Clin Pathol 2001; 116: 225-32.
20. Wolinsky E. Nontuberculous mycobacteria and associated disease. Am Rev Respir Dis 1979; 119: 107-59.
21. Safdar A, Bains M, Polsky B. Clinical microbiological case: refractory chest wall infection following reconstructive surgery in a patient with relapsed lung cancer. Clin Microbiol Infect 2001; 7(563-4): 577-9.
22. Alangaden GJ, Lerner SA. The clinical use of fluoroquinolones for the treatment of mycobacterial disease. Clin Infect Dis 1997; 25: 1213-21.
23. Hernanadez; AM, Arias A, Felipe A, Alvarez R, Sierra A. Determination of the in vitro susceptibility of 220 Mycobacterium fortuitum isolates to ten antimicrobial agents. J Chemother 1995; 7: 503-8.
24. Tartaglione T. Treatment of nontuberculous mycobacterial infections: role of clarithromycin and azithromycin. Clin Ther 1997; 19: 626-38.
25. Woods GL, Bergmann JS, Witebsky FG et al. Multisite reproducibility of results obtained by the broth microdilution methods for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 1999; 37: 1676-82.
26. Gillespie SH, Morrissey I, Everett D. A comparison of the bactericidal activity of quinolone antibiotics in a Mycobacterium fortuitum model. J Med Microbiol 2001; 50: 565-70.
27. Ho YI, Chan CY, Cheng AF. In-vitro activity of aminoglycoside-aminocyclitols against mycobacteria. J Antimicrob Chemother 1997; 40: 27-32.
28. Brown-Elliott BA, Wallace RJ Jr, Blinkhorn R, Crist CJ, Mann LB. Successful treatment of disseminated Mycobacterium chelonae infection with linezolid. Clin Infect Dis 2001; 33: 1433-4.